Table 1.
Baseline Characteristics of the ARIC Cohort Study at the Time of SSRI vs Non‐SSRI Antidepressant Medication Initiation (n=2027)
| SSRI (n=944) | Other Antidepressants (n=1083) | |
|---|---|---|
| Age, ya | 70 (10.5) | 59.8 (8.7) |
| Sex, women, % | 71.1 | 70.8 |
| Race, black, % | 16.4 | 27.0 |
| BMI, kg/m2 a | 29.2 (6.3) | 28.6 (6.1) |
| SBP, mm Hga | 123.9 (18.6) | 123.1 (18.6) |
| DBP, mm Hga | 70.8 (9.9) | 72.8 (10.9) |
| Current smoker, % | 13.5 | 21.1 |
| Current alcohol drinker, % | 47.8 | 43.1 |
| HTN treatment, % | 62.6 | 57.3 |
| Diabetes mellitus, % | 19.8 | 23.7 |
| MI history, % | 5.8 | 2.7 |
| HF history, % | 5.5 | 3.4 |
| AF history, % | 6.1 | 2.1 |
| Vital exhaustion, median (IQR)b | 13 (6–21) | 14 (8–22) |
| Initiation after 1994, % | 82.5 | 38.0 |
AF indicates atrial fibrillation; ARIC, Atherosclerosis Risk in Communities study; BMI, body mass index; DBP, diastolic blood pressure; HF, heart failure; HTN, hypertension; IQR, interquartile range; MI, myocardial infarction; SBP, systolic blood pressure; SSRI, selective serotonin reuptake inhibitor.
a
Continuous variable given as mean (SD).
b
Continuous variable given as median (IQR).